Machine Learning in Swiss bioinformatics: applications and challenges

A new version of ChromosomeWalk offers a gateway to an entertaining ‘genome browser’, enriched with a new selection of stories on fascinating genes – in English, French and German – as well to the PrecisionMed website for an illustrated tour of precision medicine.

Collaborating with Cellestia Biotech to launch new drug discovery program

Cellestia Biotech is initiating a new drug discovery program focused on TFs. The programme, which addresses unmet medical needs in cancer, autoimmune and inflammatory disorders (AIIDs), is launched in collaboration with Vincent Zoete

A key ingredient of Swiss precision oncology: SVIP-O goes live

The Swiss Variant Interpretation Platform for Oncology (SVIP-O) was launched by SIB, ETH Zurich and HES-SO to offer a harmonized interpretation of cancer variants to clinicians. SVIP-O, now available in its first public version,

Discover the world of biomedicine with the new ChromosomeWalk.ch

A new version of ChromosomeWalk offers a gateway to an entertaining ‘genome browser’, enriched with a new selection of stories on fascinating genes – in English, French and German – as well to the PrecisionMed website for an illustrated tour of precision medicine.

In memoriam: Guy-Olivier Segond, first President of SIB’s Foundation Council

On 12 November 2020, Geneva State Councillor Guy-Olivier Segond passed away at the age of 75. It is thanks to his visionary nature that SIB was established in 1998.

The SPHN fact-sheet 2020 is out

Find out about the current status of the Swiss Personalized Health Network (SPHN) – a project of the Swiss Academy of Medical Sciences (SAMS) and SIB -, its perspectives and goals for the next funding period.

Outreach resources to understand the biology of the coronavirus

A new workshop for classrooms offers the opportunity to discover the SARS-CoV-2 coronavirus, in particular its genome and proteins. These materials result from a partnership between SIB and the University of Lausanne (SCMS).

SIB becomes a partner of QCMD for quality assessment programmes

SIB is a new bioinformatics partner of the QCMD (Quality Control for Molecular Diagnostics) organization. The partnership aims to enhance bioinformatics solutions for international molecular external quality assessments.